2Storm G,Belliot S O,Daemen T,et al.Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system[J].Adv Drug Deliv Rev,1995,17:31-48.
3Mitra S,Gaur U,Gosh P C,et al.Tumor targeted delivery of encapsulated dextran-doxorubicin conjugate using chitosan nanoparticles as carrier[J].J Control Release,2001,74:317-323.
4Nishioka Y,Yoshino H.Lymphatic targeting with nanoparticulate system[J].Adv Drug Deliv Rev,2001,47:55-64.
5Xu Y M,Du Y M.Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles[J].Int J Pharm,2003,250:215-226.
6Gan Q,Wang T.Chitosan nanoparticle as protein delivery carrier-Systematic examination of fabrication conditions for efficient loading and release[J].Coll Surf B,2007,59:24-34.
7Shu X Z,Zhu K J.The influence of multivalent phosphate structure on the properties of ionieally cross-linked chitosan films for controlled drug release[J].Eur J Ph B,2002,54:235-243.
